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Background: Cryopreservation and transplantation of ovarian tissue is one option for re-establishing ovarian
function, but optimal conditions for graft sustainment and follicular survival are still considered experimental. The
present study aims to analyze the effect of FSH treatment on the resting follicle pool in fresh and cryopreserved
primate ovarian tissues following xenografting.
Methods: Ovarian tissues from adult marmosets were grafted freshly or following cryopreservation to
ovarectomized nude mice treated with FSH 25 IU twice daily post transplantation or left untreated as controls.
Grafts were retrieved 2 or 4 weeks after transplantation to evaluate the number and morphological appearance of
follicles.
Results: Early start of FSH treatment within 1 week following transplantation partly prevents primordial follicle loss
in fresh and frozen-thawed tissues, whereas after a 3 weeks time interval this effect is present only in fresh tissues.
A similar positive effect of early, but not later FSH treatment on primary follicles is seen in fresh tissues compared to
only marginal effects in frozen-thawed tissues. The percentage of morphologically normal follicles is generally
increased in FSH treated tissues, whereas the percentage of primary follicles over all primordial and primary follicles
is increased by FSH only in freshly-grafted tissues.
Conclusions: FSH treatment alleviates depletion of the resting follicle pool and promotes normal follicular
morphology both in freshly and frozen-thawed grafted tissues. In previously cryopreserved tissues, applying to most
of the tissues intended for clinical use in fertility preservation attempts, its positive effect on primordial follicle
numbers and potential graft sustainment is dependent on an early start of treatment within one week of
transplantation.
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Increasing cancer survival rates and awareness of fertility
as a quality of life issue in long-term cancer survivors
have fuelled the growing demand for fertility preserva-
tion in recent years [1]. In females, cryopreservation of
ovarian tissue is one option to preserve fertility from the
potentially harmful iatrogenic effects of chemotherapy
or irradiation: it bears the advantage of a large follicular
number to be stored for future re-establishment of ovar-
ian function both in reproductive and endocrinological
terms [2]. Successful application in human cancer survi-
vors has been documented by more than ten reported
live births so far. Furthermore, potential long-term sur-
vival of grafted tissue has been documented [3,4]. Des-
pite these promising results from a few centers with
expertise, conditions of tissue preparation, storage and
usage still require further research.
Xenografting has primarily been used as a tool to
study follicular development and exclude potential re-
introduction of malignant cells by homologous retrans-
plantation. Mostly laboratory and domestic animal
models have been employed [5], but in some aspects,
e.g. follicular recruitment and growth, the non-human
primate model may offer better comparability. The com-
mon marmoset has served as a model for human
reproduction because of its 28-day ovarian cycle, mul-
tiple, non-seasonal ovulations in each cycle, and small
size as well as high fecundity in captivity. Recently, re-
finement of ovarian stimulation to compensate for the
relative insensitivity to human gonadotrophins allowed
retrieving large numbers of mature and developmentally
competent oocytes [6]. Although the marmoset requires
unusually high doses of FSH and hCG for superovula-
tion compared with other non-human primates or
humans, a recent in vitro study has confirmed equal ef-
fectiveness of human recombinant FSH compared to
marmoset FSH on the marmoset FSH receptor [7].
Therefore, the marmoset as a non-human primate
model can further promote success in cryopreservation
of human ovary tissues for fertility preservation, as the
accessibility of human ovarian tissue for experimental
studies is highly limited and data are physiologically
closer to humans than those retrieved in the more com-
mon murine models.
We have previously evaluated the effect of cryopreser-
vation on marmoset ovarian tissue using a xenograft
model [8], demonstrating resumption of follicular
growth and sustained graft viability [9]. As was previ-
ously demonstrated in other species, xenografting sig-
nificantly challenged follicular numbers and morphology
in that study. Additionally, the effect of ovarectomy on
the ratio of primary to primordial follicles had lead us to
speculate about the role of gonadotrophins on the rest-
ing follicle pool as the major determinant of extendedgraft survival. Although most human live births follow-
ing ovarian tissue cryopreservation and retransplantation
so far have resulted from spontaneous conception [10],
FSH treatment for mild stimulation [11] or IVF treat-
ment [12] may be additionally employed. FSH is the
major regulator of advanced follicular growth depending
on the presence of FSH receptor from the antral follicle
stage on. As follicles do not have functional FSH recep-
tors until the secondary stage, FSH is unlikely to exert
direct actions on primordial or primary follicles, because
functional gonadotrophin receptors have not yet devel-
oped in them. However, indirect effects of FSH on the
non-growing follicle pool involving intraovarian regula-
tory mechanisms, stromal or endothelial factors, and
those being produced during advanced follicular growth
have been hypothesized upon [13]. In this context, the
possible benefits of FSH treatment for enhanced grafting
conditions or antral follicle development must be
balanced against presumable effects to follicular recruit-
ment decisive for long-term survival of the graft. The
present study aims to analyze the effect of FSH treat-
ment on the resting follicle pool in fresh and cryopre-
served primate ovarian tissues following xenografting.
Methods
Animals
All handling and experimental procedures concerning
the animals utilized in this study were in accordance
with the German animal protection law (license no. AZ
50.0835.1.0).
Ovarian tissues were taken from 10 healthy female
common marmosets with proven fertility aged between
2 and 3 years originating from the breeding colony of
our institute’s animal research unit. Handling of animals
and tissues was grossly as described previously [8], with
some modifications owing to the study purpose as
detailed below. Directly upon removal, ovaries were
rinsed briefly in phosphate buffered saline (PBS, Gibco,
Paisley, UK), transferred into fresh PBS supplemented
with human serum albumin (HSA, 4 mg/mL, Irvine
Scienfific, Irvine, USA) and dissected under microscopic
control at room temperature. Fragment sizes of 1–2 mm3
were used in all experiments. Control tissues were fixed
immediately; remaining tissues were either grafted freshly
or assigned to cryopreservation with dimethylsulfoxide
(DMSO).
Cryopreservation
Cryopreservation was performed with PBS containing
DMSO (1.5 mol/L, Merck, Darmstadt, Germany), su-
crose (0.5 mol/L, Sigma Aldrich) and HSA (10 mg/mL).
Fragments were gently agitated at room temperature
(RT) for 20 minutes (min), transferred into cryostraws
(Consarctic, Schoellkrippen, Germany) with 0.5 mL of
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lowing a slow-freezing protocol [14] in a controlled rate
programmable freezing system (Consarctic): starting at
RT, the cooling rate to – 7°C was 2°C/min. Seeding was
induced manually at −7°C. Cooling then continued at
0.3°C/min to −40°C followed by −10°C/min to −150°C.
Cryostraws were subsequently immersed in liquid nitro-
gen and stored for a minimum time period of 2 weeks.
On the day of transplantation, ovarian tissue fragments
were thawed following a rapid procedure: straws were
warmed at room temperature for 40 seconds and then
immersed in a water bath at 30°C until all ice crystals
vanished. The contents of the straws were then released
into cryoprotectant solution. The cryoprotectant was
removed by washing the tissue fragments in the same
solutions used for cryopreservation in reversed order
with decreasing concentrations (75, 50 and 25% of the
original concentration) at RT for 5 min each followed
by PBS (with 10 mg/mL HSA) and either grafted as
quickly as possible or fixed for histological evaluation
(see below).
Surgical procedures
32 Nu/Nu nude mice (Crl:NU-FoxnInu) were obtained
(Charles River Germany, Sulzfeld, Germany) and housed in
the central animal facility of the university for at least one
week prior to procedures. The environment was air filtered
with a 12-hour light: 12-hour dark cycle at 23°C; all ani-
mals had free access to sterilized food and water. Ovarec-
tomies were carried out two weeks prior to grafting
through a dorsomedian incision; surgical procedures were
performed under a laminar flow hood in aseptic condi-
tions. The animals were anesthetized with 0.15 mg/g body
weight ketamine and 2% (v/v) xylazine intraperitoneally
(IP). They were kept on a warming plate; eye protection
was carried out with humidified sterile swabs. On the day
of transplantation, mice received 6–8 grafts per animal.
For best accessibility and to achieve a maximum number
of grafts per host animal the tissue was placed in subcuta-
neous pouches formed with a blunt probe in a small inci-
sion in the dorsal skin. Each graft was placed in an
individual subcutaneous pouch. The grafting experiments
have been carried out in multiple rounds to ensure optimal
technical handling and minimize the number of animals to
be sacrificed. Grafting procedure was scheduled to the
availability of freshly donated ovarian tissue. For cryopre-
served tissues, storage time was a minimum of 4 weeks,
and could also be longer without effect on later analysis To
avoid bias inflicted by different endogenous hormonal mi-
lieus of the recipients, cryopreserved fragments from both
treatment groups along with fresh control tissues were
transplanted to every mouse except in the first round of
experiments, when only fresh tissue was grafted. The graft-
ing pattern (3–4 grafts were placed on either side of thespinal column) was recorded in all animals for easy identi-
fication of the grafts at the end of the experiment. Pouches
were sutured with 5/0 vicryl sutures. No animal died dur-
ing surgery or was lost prior to the end of the experiment.
FSH treatment of xenografted ovarian tissue
In the treatment group, 16 mice bearing an equal num-
ber of fresh and frozen grafts were stimulated with 25
IU of FSH i.m. (Gonal-F, MerckSerono, Darmstadt,
Germany), twice daily [15] for 6 consecutive days begin-
ning either one week (8 animals) or 3 weeks (8 animals)
after transplantation of the grafts. Timing of FSH treat-
ment and explantation relative to previous grafting pro-
cedure is detailed in Figure 1.
Graft retrieval and procession of tissue
On the day of graft explantation, the mice were
sacrificed by cervical dislocation. Grafts were retrieved
either 2 or 4 weeks after the transplantation procedure
(Figure 1) and immediately fixed in 4% paraformalde-
hyde (Sigma Aldrich). Following fixation, tissues were
dehydrated in a graded ethanol series, clarified with xy-
lene and routinely embedded in paraffin wax. Serial
sections of 5 μm thickness were cut; every fifth section
was stained with haematoxylin-eosin (HE) and analysed
with a light microscope (Axiophot, Zeiss, Oberkochen,
Germany) under a 400 fold magnification. The thickness
of tissue sections was determined based on follicle sizes
and previous work with marmoset and primate ovarian
tissue [16,17]. Marmoset primordial follicles have a
diameter of 30 μm, increasing up to 45–85 μm in pri-
mary follicles [18]. On the opposite end, small follicles
with a nucleus < 19 μm are considered non-growing in
primates [19]. Given these numbers, the aforementioned
tissue section thickness is adequately chosen to detect
the large majority of follicles while at the same time pre-
vent double-counting of follicles. An additional oocyte
staining technique has therefore not been employed.
Histological evaluation
All sections were analyzed by a single investigator
blinded to the experimental groups. In the analyzed sec-
tions, all follicles were counted. To avoid over counting,
follicles were only counted when the nucleus of the
oocyte was observed in the section. The developmental
stages of the follicles were classified according to
Gougeon [20]: the oocyte of a primordial follicle is sur-
rounded by a single layer of flattened granulosa cells
(GCs) or a mixture of flattened and cuboidal GCs. In a
primary follicle, the single GC layer is cuboidal; a sec-
ondary follicle displays two or more layers of GCs; in a
preantral follicle small fluid-filled cavities are observed
between the GCs and in the antral follicle an antrum is
distinguishable.
Figure 1 Experimental design. Recipient mice were ovarectomized (OV) bilaterally 2 weeks prior to transplantation (TP) of fresh or frozen adult
marmoset ovarian tissue from various donor animals as detailed in Table 1. Mice assigned to the treatment groups received a twice daily i.m
injection of recombinant human Follitropin beta (25 IU) for 6 days starting 1 week prior to sacrifice; control animals were left untreated. All
animals were sacrificed for graft retrieval as indicated (red arrows) either 2 (8 animals in each group) or 4 weeks (8 animals in each group) post
transplantation.
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viously [8] based on variables such as integrity of the oo-
cyte, the GCs and the basement membrane. Follicles
were classified as morphologically normal if they showed
no pyknosis of the oocyte nucleus, no disorganized or
detached GCs or shrunken ooplasm.
In general, data are presented as mean numbers of follicles
per section for each subclass (primordial and primary folli-
cles) of the resting follicle pool. Additional analyses have
been included where appropriate to stress more subtle func-
tional aspects concerning follicular morphology (presented
as percentage of morphologically normal follicles over all
follicles counted) and percentage of primary follicles calcu-
lated over all un-advanced follicles (primordial and primary)
reflecting activation process in the resting follicle pool.
Statistical analysis
Comparisons between two experimental groups were
carried out using student´s t-test, and in case of more
than two experimental groups ANOVA was performed
with Tamahane for posthoc comparisons in case of stat-
istical significance. Values were considered statistically
significant with P < 0.05 and are presented as mean +/−
SE. Data analysis was carried out utilizing SPSS for
Windows (Version 15.0). Different letters upon bars in-
dicate statistical significance in all graphs.
Results
Histological analysis of xenotransplanted frozen ovarian
tissues
Following 2 and 4 weeks after xenotransplantation a
total of 127 grafts were retrieved amounting to a graftTable 1 Assignment of adult marmoset ovarian tissue fragme
No. of donor animals (n) Experimental group Overall no. of tis
10 Freshly fixed 5/50
Freshly grafted 10/100
Frozen grafted 10/100retrieval rate of 63.5% not differing significantly between
experimental groups. The total number of analysed folli-
cles in the different treatment groups is given in Table 1.
Examples for the morphology of untreated (Figure 2A)
frozen-grafted tissue and frozen-grafted tissue treated
with FSH (Figure 2B) are shown in Figure 2. Even
though cryopreservation and initial ischemia post graft-
ing severely challenges follicular morphology, advanced
follicles found in grafted tissues and the oocytes within
displayed a grossly intact morphology (Figure 2D). How-
ever, the total number of secondary, pre-antral and an-
tral follicles (Figure 2C) remained insufficiently low to
perform statistical analysis in all treatment groups.
Xenografting of ovarian tissue leads to a dramatic ini-
tial loss of follicles compared to the pre-graft status of
the tissue, which is even more pronounced if the tissue
is transplanted following cryopreservation: the mean
number of un-advanced (primordial and primary) folli-
cles per section of untreated cryopreserved ovarian tis-
sue is significantly reduced from 45.3+/−5.1 (pregraft) to
6.8+/−0.7 (p=0.001) at 2 weeks after transplantation, and
to 7.6+/−2.2 (p=0.001) at 4 weeks after transplantation.
FSH effects on follicular loss in fresh and frozen-thawed
tissues following xenotransplantation
Irrespective of FSH treatment, the overall number of un-
advanced follicles is substantially higher in freshly grafted
tissues compared to tissues grafted after cryopreservation
[mean number of un-advanced follicles per section after
grafting for 2 weeks: 37.5+/−2.5 (fresh) vs 8.2+/−0.9
(frozen), p=0.000; mean number of un-advanced follicles
per section after grafting for 4 weeks: 36.0+/−3.1 (fresh) vsnts to experimental groups




Figure 2 Typical morphology of frozen-thawed ovarian tissues following grafting with or without FSH. After a grafting period of 4 weeks,
cryopreserved adult marmoset ovarian tissues treated with FSH (B, overview; C, D) displayed all types of follicles including antral (C) with largely
intact morphology (D). Density of follicles advanced past primary stage (B, arrowheads) appeared higher than in unstimulated tissues (A, overview),
but was not evaluated systematically due to low total number of tissue sections with advanced follicles.
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fluence on mean primordial follicle numbers (Figure 3A):
these remain unchanged from 2 weeks (33.2+/−2.5 follicles
per section) to 4 weeks (30.8+/−2.5; p = 0.5) after trans-
plantation for untreated tissues.
Treatment with FSH for 6 days prior to explantation
rescues follicle numbers to a certain extent compared to
untreated tissues: in freshly grafted tissues, FSH applica-
tion results in a significantly higher mean primordial fol-
licle number per section in treated (81.3+/−10.2, at 2Figure 3 A and B Effect of FSH treatment on primordial follicle numb
(A) at 2 and 4 weeks post grafting. In frozen tissues (B) this effect is presenweeks after transplantation) compared to untreated tis-
sues (33.2+/−2.5 at 2 weeks after transplantation,
p=0.001; Figure 3A). This protective effect remains un-
changed even when postponing the start of FSH applica-
tion to 3 weeks after grafting (Figure 3A, 4 wks;
p=0.000). Grafting duration, however, did not influence
mean primordial follicle number in FSH treated tissues.
In frozen-grafted tissues, mean primordial follicle
numbers were likewise positively effected by FSH treat-
ment (34.2+/−3.7, FSH vs 4.9+/−0.9, untreated; p=0.000;ers. FSH-treatment prevents loss of primordial follicles in fresh tissues
t at 2 weeks but reversed at 4 weeks post grafting.
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transplantation (explantation at 2 weeks post grafting).
At 4 weeks post grafting, mean primordial follicle
numbers were significantly lower in the FSH group
(4.3+/−0.6, FSH vs 8.2+/−2.4, untreated; p=0.019), whereas
mean primordial follicle number did not change over time
in the untreated group (p=0.472, Figure 3B).
For primary follicles, a positive effect of FSH treatment
on mean number is present in freshly grafted tissues at 2
weeks (p=0.008) but not at 4 weeks (p=0.131; Figure 4A)
post grafting. In frozen-grafted tissues, mean primary
follicle numbers are significantly higher in FSH treated
tissues at 2 weeks (p=0.02) and at 4 weeks (p=0.010;
Figure 4B) post grafting. The pool of primary follicles is
decreased over time in both groups (untreated and FSH,
p<0.05; Figure 4B).
FSH promotes follicular morphology following
xenotransplantation
Cryopreservation and grafting both challenge follicular
morphology to a high extent. FSH treatment prior to graft
explantation, however, has a protective effect on the morph-
ology of primordial and primary follicles (Figure 5A and 5B):
A significantly higher percentage of freshly grafted pri-
mordial follicles in the FSH group display normal morpho-
logical features (25.7+/−2.2%) than in the untreated group
(18.2+/−2.5%, p=0.006, Figure 5A). In frozen tissues, the per-
centage of morphologically normal primordial follicles is also
higher in the FSH group (39.8+/−2.8%) than in the untreated
group (26.4+/−5.2%, Figure 5B), but this difference does not
reach statistical significance (p=0.074).
Likewise, a supportive effect of FSH treatment on
primary follicle morphology is found in fresh (p=0.001;Figure 4 A and B Effect of FSH treatment on primary follicle numbers
primary follicles in fresh ovarian tissues (A) at 2 weeks, but not 4 weeks po
number. In frozen tissues (B), the pool of primary follicles is decreased over
significantly increases the mean number of primary follicles 2 weeks and 4Figure 5A) and frozen-thawed (p=0.000; Figure 5B) tis-
sues and seems to be even more pronounced than in
primordial follicles.
Proportions of primary follicles in grafted tissues are
influenced by FSH treatment and previous
cryopreservation
Changes in the proportion of primary follicles in the
resting follicle pool may mirror the beginning of follicu-
lar recruitment. Before xenografting, the proportions of
primary follicles are not significantly different between
fresh (33.9+/−2.9%) and frozen-thawed (29.9+/−2.9%)
ovarian tissues. In freshly grafted tissues, these propor-
tions decrease significantly after transplantation and
then remain stable over time (p=0.000; Figure 6A). FSH
treatment prior to graft explantation substantially
diminishes this effect at both 2 (p=0.015) and 4 weeks
(p=0.04) post grafting (Figure 6A).
In frozen-thawed ovarian tissue, the proportion of pri-
mary follicles is significantly increased at 2 weeks after
grafting in untreated (p=0.000), but not FSH-treated tis-
sues (p=0.411; Figure 6B), reflecting a relatively smaller
loss of primary compared to the dramatic loss of primor-
dial follicles. At 4 weeks after transplantation, the pro-
portions of primary follicles are increased in both
untreated and FSH treated tissues compared to pregraft
values, but largely unaffected by FSH treatment itself
(p=0.458; Figure 6B).
Discussion
The size of the resting follicle pool determines the ovar-
ian reserve of an individual and correlates with graft sus-
tainment after restoration of fertility by ovarian tissue. FSH treatment results in significantly higher mean numbers of
stgraft, with no effect of grafting duration on mean primary follicle
time in both FSH treated and untreated tissues, and FSH treatment
weeks after grafting.
Figure 5 A and B Increased normal follicular morphology following FSH treatment. The percentage of follicles with normal morphology
following grafting for up to 4 weeks in fresh (A) as well as frozen-thawed ovarian tissue (B) is higher in FSH-treated recipients.
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ovarian reserve following ovarian tissue transplantation
is challenging when using established markers and indi-
cates high variability between patients [21]. Besides age
of the donor [22] and ongoing recruitment of follicles
into the maturation pathway, it is challenged by external
influences such as previous transportation [23], cryo-
preservation procedure and grafting conditions [24].
Xenografting to ovarectomized versus intact animals has
previously been considered to be beneficial for graft sur-
vival and growth due to elevated gonadotropin levelsFigure 6 A and B Proportions of primary follicles in grafted tissues. T
compared with the pregraft control in freshly grafted tissues (A), but to a s
FSH treated tissues, the proportion of primary follicles is increased at 2 wee
and at 4 weeks this increase is significant in FSH-treated tissues only.following interruption of the inhibitory pituitary feed-
back loop [25,16]. Gonadotrophin treatment has been
variously studied in its effect on cytoplasmic maturation
and oocyte developmental competence in different spe-
cies including pig [26], mouse [27] and the monkey
model [28]. There are anecdotal reports on a possible ef-
fect of FSH on cyctoplasmic maturation in human
oocytes [29], but the question of FSH effects on the rest-
ing follicle pool in human ovarian tissues has rarely been
addressed systematically. Oktay has described FSH influ-
ence on follicular growth at earlier stages thanhe proportion of primary follicles drops to much lower values
maller extent when preceded by FSH treatment. In untreated but not
ks compared to pregraft values in frozen-thawed ovarian tissue (B),
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ence of primordial follicle growth inititation from gona-
dotrophins [30]. The value of FSH stimulation for
obtaining pregnancy in patients with autologous trans-
plantation of ovarian tissue is still a matter of debate
[31].
Enhanced follicular depletion through FSH effects dur-
ing ovarian stimulation has anecdotally been reported in
the human [32], but controlled experimental studies on
the effect of FSH on the resting follicle pool are still
missing. According to our results in the present study,
initial loss of primordial and primary follicles after graft-
ing of fresh or frozen-thawed tissues is rescued at least
in parts by FSH treatment starting within the 2nd week
of transplantation. In freshly but not in frozen-thawed
grafted tissues, a positive effect of FSH treatment on
primordial follicle number was also observed if the
start of treatment was postponed to 3 weeks post trans-
plantation. As we have previously documented in the
marmoset [8], and others in different species [14,33,34],
cryopreservation applying a slow-freeze protocol signifi-
cantly reduces normal follicular morphology in the rest-
ing follicle pool. In the present paper, we have also
assessed the dramatic initial follicular loss following
xenografting of frozen-thawed tissue. It is assumed that
tissue damages occurring during cryopreservation and
the initial avascular period after grafting are masked by a
more receptive host milieu in FSH treated tissues. This
is also supported by higher numbers of normal follicular
morphology following FSH treatment in frozen-thawed
as well as fresh tissues at all different points in time. A
positive effect of FSH on follicle survival in frozen-
thawed ovarian tissue applying an in vitro co-culture sys-
tem had previously been described for other non-human
primates [28]. In human ovarian tissue that was cryopre-
served and xenografted to the murine back muscle,
earlier beginning of vessel formation had been demon-
strated following FSH stimulation [35], thus enhancing
the supply with nutritional and differentiating factors.
Interestingly, FSH receptor expression had been des-
cribed for tumor blood vessels in various organs [36],
and for ovarian surface epithelium [37], suggesting that
its effect on follicular morphology is rather an indirect
one and not transmitted through granulosa cells as the
classical target of FSH action.
When started after a prolonged grafting period of fro-
zen tissues, FSH negatively influences primordial follicle
numbers that are already low and most likely at this
point reflect manifestation of preceding tissue damages
due to cryopreservation. Since primary follicle numbers
are increased in these tissues, the reduction in the prim-
ordial follicle pool may additionally mirror the beginning
of follicular recruitment becoming apparent in already
low primordial follicle numbers. However in freshtissues, baseline values of follicle numbers are higher
also after a prolonged grafting period, and FSH treat-
ment following early or at a later point in time after
transplantation prevents primordial follicle loss. This is
in agreement with viability studies on fresh and frozen
ovarian tissue resulting in significantly reduced viability
when applying a slow-freezing protocol [4].
Proportional analysis of primary and primordial follicle
number can indicate initiation of follicular growth, and
for xenografted human ovarian tissue the influence of
cryopreservation [38] and timing of FSH stimulation
[39] on primordial follicle activation has been speculated
upon. However, in this study we have not applied any
staining techniques as a definitive marker of prolifera-
tion, and higher percentages of primary follicles over all
un-advanced follicles in FSH-treated freshly-grafted tis-
sues cannot be clearly assigned to a shift from the prim-
ordial to the primary follicle compartment. From a
clinical point of view this may be of outstanding import-
ance for the efficacy of ovarian tissue grafting for fertility
restoration as the majority of stored human tissues today
have most likely been treated according to a slow freez-
ing protocol, and lower chances of pregnancy from these
tissues compared with fresh or vitrified tissues are dis-
puted [10]. We have previously discussed the impact of
cryopreservation per se on follicle pool dynamics and
primary follicle activation in adult and prepubertal ovar-
ian tissues [8]. This could rather indicate absence of in-
hibitory signals deriving from the stromal cells due to
cryodamages than an increase in activating factors [40].
As the present study has not included in depth analysis
of factors potentially involved in follicular growth and
activation, involvement remains speculative. We can
only assume possible secondary effects, e.g. via recruit-
ment of antral follicles, as these were too small in num-
ber to be analyzed statistically between FSH-treated and
untreated tissues. In view of an increasing clinical appli-
cation of ovarian tissue grafting based on previously
cryopreserved human tissues, these results may further
stimulate research on intraovarian factors involved in
the regulation of the resting follicle pool and positively
influence clinical outcomes.
Conclusions
FSH treatment alleviates depletion of the resting follicle
pool and promotes normal follicular morphology both in
freshly and frozen-thawed grafted tissues. In previously
cryopreserved tissues, applying to most of the tissues
intended for clinical use in fertility preservation
attempts, its positive effect on primordial follicle num-
bers and potential graft sustainment is dependent on an
early start of treatment within one week of transplant-
ation. Whereas in fresh tissues FSH treatment following
xenografting results in a higher percentage of primary
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independent of FSH in frozen-thawed tissues.
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